Immunotherapy and Immunotherapeutics laboratories may also do the following tests:

Clinical Trials: Phases I to IV to assess safety efficacy and dosing of immunotherapeutics Testing
Immunogenicity Testing: Evaluates whether a therapeutic triggers an immune response against itself potentially reducing its effectiveness Testing
Cell Viability and Proliferation Assays: Tests the ability of immune cells to survive and multiply in response to therapeutics Testing
Cytotoxicity Tests: Measures the ability of immune cells to kill cancer or infected cells after treatment Testing
Biomarker Testing: Identifies specific molecules that indicate the effects of the therapy on the immune system Testing